tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ARWR is currently covered by 9 analysts with an average price target of $85.89. This is a potential upside of $15.68 (0.61%) from yesterday's end of day stock price of $85.37.
Arrowhead Pharmaceuticals's activity chart (see below) currently has 200 price targets and 199 ratings on display. The stock rating distribution of ARWR is 75% BUY and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 81.98% with an average time for these price targets to be met of 385.79 days.
Highest price target for ARWR is $126, Lowest price target is $35, average price target is $85.89.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 30-Aug-2026. First documented stock forecast 07-Feb-2014.
Currently out of the existing stock ratings of ARWR, 24 are a BUY (75%), 8 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2020
$115
$32.61 (39.58%)
$115
Buy Since 12-May-2020
$100
$17.61 (21.37%)
$87
Buy Since 24-Sep-2015
$126
$43.61 (52.93%)
$110
Buy Since 22-Jul-2026
$120
$37.61 (45.65%)
$100
Hold Since 25-May-2023
$72
$-6.89 (-8.73%)
$21
What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?
